Evidence map›Paper›PMID 19034683›Full record

ArticleTransgenic research2009

A caveat in mouse genetic engineering: ectopic gene targeting in ES cells by bidirectional extension of the homology arms of a gene replacement vector carrying human PARP-1.

Aswin Mangerich, Harry Scherthan, Jörg Diefenbach, Ulrich Kloz, Franciscus van der Hoeven, Sascha Beneke, Alexander Bürkle

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Aswin MangerichMolecular Toxicology Group, Department of Biology, University of Konstanz, Box X911, 78457, Constance, Germany.
Harry Scherthan
Jörg Diefenbach
Ulrich Kloz
Franciscus van der Hoeven
Sascha Beneke
Alexander Bürkle
University of Konstanz · DEHeidelberg University · DEBundeswehr Medical Service Academy · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we report an approach to generate a knock-in mouse model using an 'ends-out' gene replacement vector to substitute the murine Parp-1 (mParp-1) coding sequence (32 kb) with its human orthologous sequence (46 kb). Unexpectedly, examination of mutant ES cell clones and mice revealed that site-specific homologous recombination was mimicked in three independently generated ES cell clones by bidirectional extension of the vector homology arms using the endogenous mParp-1-flanking sequences as templates. This was followed by adjacent integration of the targeting vector, thus leaving the endogenous mParp-1 locus functional. A related phenomenon termed 'ectopic gene targeting' has so far only been described for 'ends-in' integration-type vectors in non-ES cell gene targeting. We provide reliable techniques to detect such ectopic gene targeting which represents an unexpected caveat in mouse genetic engineering that should be considered in the design and validation strategy of future gene knock-in approaches.

Indexed as

AnimalsCloning, MolecularCrosses, GeneticEmbryonic Stem CellsGene Knock-In TechniquesGene TargetingGenetic EngineeringGenetic VectorsHeterozygoteHumansIn Situ Hybridization, FluorescenceMiceModels, GeneticPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesRecombination, GeneticPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerases

Identifiers

PMID19034683
OpenAlexW2057747580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.